Saturday 7 November 2026 Export AGIO’s income statement to Excel — free account

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $54.0 million, up 48.0% from fiscal 2024.

Revenue: +330.0%
EPS: +38.8%
Free cash flow: +32.6%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

29.41 1.14 +4.03%

Follow AGIO

Alert me

Market cap: $1.7B
P/E: 0.0×
Fwd P/E: −5.1×
Dividend yield: —
F-score: 3/9
Altman Z: 8.12
Beneish M: −1.72
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(32.95%)	(34.34%)	(32.82%)	(30.20%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	4	4	4	3
ROA Full definition →	(30.44%)	(31.89%)	(30.84%)	(27.89%)
ROIC Full definition →	(75.02%)	(70.24%)	(79.88%)	(87.12%)
Return on Tangible Assets Full definition →	(54.45%)	(62.56%)	(53.73%)	(47.41%)
Average Days of Receivables Full definition →	0.00	74.65	89.15	71.46
Free Cash Flow per Share Full definition →	(5.63)	(6.14)	(6.54)	(6.51)
Free Cash Flow Full definition →	(335.97)	(365.25)	(384.73)	(377.29)
Capital Expenditures Full definition →	(4.28)	(4.66)	(4.32)	(4.32)
Other line items
Cash ROIC Full definition →	(20.88%)	(22.22%)	(20.84%)	(18.43%)
Accounts Receivable Turnover Full definition →	0.00	7.84	6.78	7.36
Accounts Payable Turnover Full definition →	0.44	0.46	0.48	0.36
Inventory Turnover Full definition →	0.00	0.26	0.20	0.21
Average Days of Payables Full definition →	834.28	757.77	762.68	1,055.88
Days of Inventory on Hand Full definition →	0.00	1,397.88	1,946.61	1,893.74
Tax Rate Full definition →	—	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	243.85%	362.78%	526.80%	628.44%
Selling, General and Administrative Expense of Revenue Full definition →	147.68%	195.99%	283.21%	333.68%
Share Based Compensation of Revenue Full definition →	44.22%	58.96%	85.90%	97.27%
Operating CF/Net income Full definition →	0.89	0.88	0.90	0.90
Depreciation/Fixed assets Full definition →	0.05	(0.03)	(0.16)	(0.19)
Capex/Depreciation Full definition →	(8.83)	13.50	2.50	2.14
Revenue per Share Full definition →	2.36	1.65	1.12	0.93
Operating CF per Share Full definition →	(5.56)	(6.06)	(6.47)	(6.43)
Capex per Share Full definition →	(0.07)	(0.08)	(0.07)	(0.07)
Capex to Sales Full definition →	0.03	0.05	0.07	0.08

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly